Azenta, Inc. (NASDAQ:AZTA) Shares Purchased by Quest Partners LLC

Quest Partners LLC grew its stake in shares of Azenta, Inc. (NASDAQ:AZTA) by 31.5% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 7,941 shares of the company’s stock after buying an additional 1,902 shares during the quarter. Quest Partners LLC’s holdings in Azenta were worth $385,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently made changes to their positions in the stock. Hantz Financial Services Inc. acquired a new stake in Azenta in the second quarter worth approximately $30,000. Farther Finance Advisors LLC raised its stake in shares of Azenta by 20.0% in the 3rd quarter. Farther Finance Advisors LLC now owns 1,537 shares of the company’s stock worth $74,000 after buying an additional 256 shares in the last quarter. Benjamin F. Edwards & Company Inc. boosted its stake in Azenta by 150.9% during the second quarter. Benjamin F. Edwards & Company Inc. now owns 1,588 shares of the company’s stock valued at $84,000 after buying an additional 955 shares in the last quarter. Lazard Asset Management LLC acquired a new position in Azenta during the first quarter worth about $130,000. Finally, Acadian Asset Management LLC raised its position in Azenta by 24.7% in the first quarter. Acadian Asset Management LLC now owns 2,381 shares of the company’s stock worth $143,000 after acquiring an additional 471 shares in the last quarter. 99.08% of the stock is owned by institutional investors and hedge funds.

Azenta Price Performance

AZTA stock opened at $45.16 on Monday. The firm has a market capitalization of $2.21 billion, a P/E ratio of -15.21 and a beta of 1.48. Azenta, Inc. has a 52-week low of $38.82 and a 52-week high of $69.16. The company’s 50 day simple moving average is $45.22 and its 200-day simple moving average is $50.05.

Azenta (NASDAQ:AZTA) last released its earnings results on Tuesday, November 12th. The company reported $0.18 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.10 by $0.08. Azenta had a positive return on equity of 1.03% and a negative net margin of 25.01%. The company had revenue of $170.00 million during the quarter, compared to analyst estimates of $169.66 million. During the same quarter in the prior year, the company earned $0.13 earnings per share. The company’s revenue for the quarter was down 1.2% on a year-over-year basis. Sell-side analysts predict that Azenta, Inc. will post 0.4 EPS for the current fiscal year.

Insider Buying and Selling at Azenta

In other news, Director William L. Cornog acquired 12,500 shares of the business’s stock in a transaction that occurred on Monday, November 18th. The stock was acquired at an average cost of $39.60 per share, for a total transaction of $495,000.00. Following the completion of the acquisition, the director now owns 14,755 shares in the company, valued at approximately $584,298. The trade was a 554.32 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO John Marotta bought 12,717 shares of the stock in a transaction on Monday, November 18th. The stock was purchased at an average price of $39.48 per share, for a total transaction of $502,067.16. Following the purchase, the chief executive officer now directly owns 99,612 shares of the company’s stock, valued at approximately $3,932,681.76. This represents a 14.63 % increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last quarter, insiders have sold 3,018 shares of company stock worth $126,689. 1.77% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on AZTA. Evercore ISI lowered their price objective on shares of Azenta from $53.00 to $50.00 and set an “in-line” rating on the stock in a research note on Tuesday, October 1st. Needham & Company LLC dropped their price target on Azenta from $69.00 to $55.00 and set a “buy” rating on the stock in a report on Wednesday, November 13th. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat, Azenta has an average rating of “Hold” and a consensus price target of $63.60.

Azenta Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.